DPP-4 Inhibitor and Sulfonylurea Differentially Reverse Type 2 Diabetes-Induced Blood-Brain Barrier Leakage and Normalize Capillary Pericyte Coverage.
Journal Information
Full Title: Diabetes
Abbreviation: Diabetes
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Endocrinology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Duality of Interest. This study received funding from Boehringer Ingelheim Pharma GmbH & Co. KG. T.K. is employed at Boehringer Ingelheim Pharma GmbH & Co. KG."
"Funding. This work was mainly supported by the Swedish Parkinson Foundation and the Åhlens Foundation and by an award from Boehringer Ingelheim Pharma GmbH & Co. KG (to C.P.), Financial support was also provided by Hjärnfonden, Diabetesfonden, Ulla Hamberg Angeby och Lennart Angebys Stiftelse, the Swedish Stroke Foundation, the Swedish Heart-Lung Foundation, and by the ALF regional agreement on medical training and clinical research."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025